SEC filing · 8-K

Corcept Therapeutics Inc: Executive or director change

Corcept Therapeutics announced that Sean Maduck will retire as President of Endocrinology and Justin Gunn will succeed him effective October 1, 2026.

Filed September 23, 2026

Neutral news

What happened

Sean Maduck notified the board on September 22, 2026, of his decision to resign as President of Corcept Endocrinology effective October 1, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Corcept Therapeutics Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.